Welcome Letter
Welcome to the 2022 Annual Report! 2022 was a mix of old and new for IASLC. We were thrilled to return to in-person events and equally excited to welcome our new CEO Karen Kelly and many wonderful new staff members. It was a year focused on providing as much benefit as possible for our members.
IASLC's International and Multidisciplinary Membership
For more than four decades, IASLC members have led a worldwide movement to advance the mission of conquering thoracic cancers across the globe. In 2022, at events such as the World Conference on Lung Cancer (WCLC), the Asia Conference on Lung Cancer, the North America Conference on Lung Cancer, the IASLC CT Screening Symposium, and the Targeted Therapies of Lung Cancer Meeting, lung cancer specialists accessed the latest research and scientific discoveries in thoracic oncology, allowing them to advance their profession through education and development opportunities.
Members By Country/Region
Members by Primary Specialty
| Labels | Values |
|---|---|
| Medical Oncology | 32.3% |
| Thoracic Surgery | 13.7% |
| Other/Unknown | 14.8% |
| Pulmonary Medicine | 9.5% |
| Cancer Research | 6.8% |
| Radiation Oncology | 6.1% |
| Pathology | 5.6% |
| Advocacy | 4.3% |
| Biotech/Pharmaceutical | 3.6% |
| Diagnostic Radiology | 1.7% |
| Nursing | 1.6% |
donut
Professional Activity/Practice
| Labels | Values |
|---|---|
| Academic Medical Center | 48.3 |
| Other/Unknown | 15.7 |
| Pharmaceutical/Biotech | 10.7 |
| Cancer Center | 10.4 |
| Private Practice (Hospital) | 3.6 |
| Private Practice (Office) | 3.1 |
| Training Program | 2.6 |
| Non-Profit or Advocacy | 1.9 |
| Laboratory Research | 1.7 |
| Government Agency | 1.1 |
| Administration | 0.5 |
| Retired | 0.4 |
donut
